European Biotech Pharming Group Touts Positive Data From Pivotal Pediatric Study Of FDA-Approved Immune System Disorder Drug

Bron: Yahoo Entertainment

Gepubliceerd op: 2024-12-11

Come proteggersi dal Phishing con l’antivirus Surfshark

Bron: Macitynet.it

Autheur: Pubblicità

Gepubliceerd op: 2024-12-10

Ecco come proteggersi dal phishing con l’antivirus Surfshark. – su macitynet.it Come proteggersi dal Phishing con l’antivirus Surfshark

Pharming Group (NASDAQ:PHAR) Now Covered by Jefferies Financial Group

Bron: ETF Daily News

Autheur: MarketBeat News

Gepubliceerd op: 2024-12-11

Research analysts at Jefferies Financial Group assumed coverage on shares of Pharming Group (NASDAQ:PHAR – Get Free Report) in a research note issued to investors on Monday, Marketbeat.com reports. The brokerage set a “buy” rating and a $14.00 price target on…

Llama SG a extremar precauciones contra fraudes

Bron: Jornada.com.mx

Autheur: DEMOS, Desarrollo de Medios, S.A. de C.V.

Gepubliceerd op: 2024-12-23

La secretaria de Gobernación, Rosa Icela Rodríguez, llamó a la población a ser precavidos ante engaños, con los que prometen grandes premios, sin haber participado en ningún concurso regulado por la dependencia.

HC Wainwright Reiterates Buy Rating for Pharming Group (NASDAQ:PHAR)

Bron: ETF Daily News

Autheur: MarketBeat News

Gepubliceerd op: 2024-12-19

Pharming Group (NASDAQ:PHAR – Get Free Report)‘s stock had its “buy” rating reissued by investment analysts at HC Wainwright in a research note issued on Tuesday,Benzinga reports. They presently have a $37.00 target price on the stock. HC Wainwright’s price t…

Pharming Group (NASDAQ:PHAR) Shares Down 3.9% – Time to Sell?

Bron: ETF Daily News

Autheur: MarketBeat News

Gepubliceerd op: 2024-12-26

Pharming Group (NASDAQ:PHAR – Get Free Report) dropped 3.9% during trading on Tuesday . The stock traded as low as $9.34 and last traded at $10.02. Approximately 1,303 shares were traded during trading, a decline of 75% from the average daily volume of 5,267 …

Pharming Group (NASDAQ:PHAR) Trading 6.1% Higher – Here’s Why

Bron: ETF Daily News

Autheur: MarketBeat News

Gepubliceerd op: 2025-01-02

Pharming Group (NASDAQ:PHAR – Get Free Report)’s share price shot up 6.1% during trading on Tuesday . The stock traded as high as $10.29 and last traded at $10.29. 2,621 shares changed hands during trading, a decline of 50% from the average session volume of …

HC Wainwright Reaffirms Buy Rating for Pharming Group (NASDAQ:PHAR)

Bron: ETF Daily News

Autheur: MarketBeat News

Gepubliceerd op: 2024-12-14

HC Wainwright reaffirmed their buy rating on shares of Pharming Group (NASDAQ:PHAR – Free Report) in a report issued on Wednesday,Benzinga reports. HC Wainwright currently has a $37.00 price target on the stock. Several other research analysts have also comme…

Pharming announces public cash offer to the shareholders of Abliva AB

Bron: GlobeNewswire

Autheur: Pharming Group N.V.

Gepubliceerd op: 2024-12-15

Proposed acquisition strengthens Pharming’s late-stage pipeline with a potential first-in-disease asset Abliva’s lead product KL1333 is currently in a……

3 Promising Penny Stocks With At Least US$80M Market Cap

Bron: Yahoo Entertainment

Autheur: Simply Wall St.

Gepubliceerd op: 2024-12-25

Amid recent global market fluctuations, with U.S. stocks experiencing a decline due to cautious Federal Reserve commentary and political uncertainties, investors are increasingly looking for opportunities in less conventional areas of the market. Penny stocks…

European Biotech Pharming Group Touts Positive Data From Pivotal Pediatric Study Of FDA-Approved Immune System Disorder Drug

Bron: Biztoc.com

Autheur: benzinga.com

Gepubliceerd op: 2024-12-11

On Wednesday, Pharming Group N.V. (NASDAQ:PHAR) revealed topline results of data from its Phase 3 trial evaluating leniolisib in children aged 4 to 11 years with activated phosphoinositide 3-kinase delta syndrome (APDS). APDS is a genetic disorder that impair…

Pharming initiated with bullish view at Jefferies, here’s why

Bron: Thefly.com

Gepubliceerd op: 2024-12-09

See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly’s real-time, streaming news feed keeps individual investors, professional money managers, active traders, and corpor…

Pharming announces positive topline data in pediatric clinical trial of leniolisib

Bron: GlobeNewswire

Autheur: Pharming Group N.V.

Gepubliceerd op: 2024-12-11

Multinational Phase III study is evaluating leniolisib tablets in children aged 4 to 11 years with APDS, a rare primary immunodeficiency Data…

IP Group to gain from life sciences buyouts

Bron: Investing.com

Autheur: Investing.com

Gepubliceerd op: 2024-12-20

IP Group to gain from life sciences buyouts

Glencore just upgraded at BMO Capital, here’s why

Bron: Thefly.com

Gepubliceerd op: 2024-12-16

See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly’s real-time, streaming news feed keeps individual investors, professional money managers, active traders, and corpor…

Pharming koopt Zweeds bedrijf: ’Veel omzetpotentieel’

Bron: Telegraaf.nl

Autheur: onze correspondent

Gepubliceerd op: 2024-12-15

Pharming heeft een bod van omgerekend $66,1 miljoen uitgebracht op Abliva. De biofarmaceut geeft aan met de overname van dit Zweedse bedrijf een geneesmiddel in huis te halen dat in potentie een jaaromzet van $1 miljard kan realiseren.

LIVE | Pharming wint op rustige beurs

Bron: Telegraaf.nl

Autheur: onze correspondent

Gepubliceerd op: 2024-12-16

De handel op het Damrak is rustig van start gegaan. Beleggers zijn in afwachting van het rentebesluit door de Fed op woensdag. Pharming wint na een overnamebod op een Zweedse branchegenoot. Havas is zijn beursdebuut goed begonnen.

LIVE | vers inflatiecijfer VS stuwt future S&P 500, AEX stabiel op winst

Bron: Telegraaf.nl

Autheur: onze correspondent

Gepubliceerd op: 2024-12-11

Beurzen in New York staan woensdagmiddag volgens de futures voor een gemengde opening nadat het nieuwe inflatiecijfer voor november in de Verenigde Staten volgens verwachting op 2,7% is gekomen. De S&P 500-index zal hoger openen, evenals de Nasdaq, maar de Do…